A Web-Based Cardiovascular Risk Assessment via Pharmacists: A Feasibility and Validation Study
Alexandra de Toledo1,2, Pascal Bonnabry3, Jean-Michel Gaspoz1, Jean-Philippe de Toledo2, Idris Guessous1,4,5*
1Division of Primary Care Medicine, Department of Community Medicine, Primary Care and Emergency Medicine, University Hospitals of Geneva, Faculty of Medicine, University of Geneva, Geneva, Switzerland.
2PP Pharmacie Principale SA, Geneva, Switzerland.
3Pharmacy, Geneva University Hospitals, Geneva, Switzerland; School of Pharmaceutical Sciences, University of Geneva, University of Lausanne, Geneva, Switzerland.
4Community Prevention Unit, University Institute of Social and Preventive Medicine, Lausanne University Hospital, Lausanne, Switzerland.
5Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, USA.
DOI: 10.4236/ojpm.2015.58039   PDF   HTML   XML   2,663 Downloads   3,569 Views  


Background: Involving pharmacists in clinical care could improve the identification of subjects at risk for cardiovascular (CV) disease. Data on web-based approach involving pharmacists for CV disease risk assessment are very limited. Methods: We first developed a web-based CV risk assessment tool to be used by pharmacists that includes demographic, lifestyle, biological and anthropometric information. Biological and anthropometric data were collected in independent laboratories. We then assessed the feasibility and validity of this approach by inviting adults who previously (within 6 months) participated in a Swiss standardized population-based study to fill out the web-based platform. Attrition rates and correlations were used to assess the feasibility and validity, respectively. Proportions were expressed as percentages and continuous variables were expressed as means ± standard deviations (SD). Main Outcomes Measure: Proportions of participants who 1) agreed to participate; 2) filled out the questionnaire and had their biological and anthropometric measures taken; 3) only filled out the questionnaire; and 4) only had their biological and anthropometric measures taken. Correlations were used to compare continuous variables (body mass index [BMI], waist circumference, systolic blood pressure, fasting blood glucose, total plasma cholesterol, HDL plasma cholesterol, LDL plasma cholesterol, triglycerides) collected via both studies. Results: Overall, 218 (53.2% women) adults of the population-based study were eligible and were contacted to participate, from April to November 2013. Of these, 140 (64.2%) agreed to participate. The majority (67/140, 47.8%) both filled out the questionnaire and had their biological/anthropometric measures taken, whereas only 2.8% and 7.1% only filled out the questionnaire or only had their biological measures taken, respectively. Except for systolic blood pressure, fasting glucose, and triglycerides, the correlations between the measures obtained in the population-based study and the web-based approach were generally greater than 0.80, suggesting very good correlations. Conclusions: A web-based CV risk assessment via pharmacists is a feasible and valid approach. This web-based approach should be adapted to lower attrition, and its impact on CV risk factors should be further tested.

Share and Cite:

Toledo, A. , Bonnabry, P. , Gaspoz, J. , de Toledo, J. and Guessous, I. (2015) A Web-Based Cardiovascular Risk Assessment via Pharmacists: A Feasibility and Validation Study. Open Journal of Preventive Medicine, 5, 348-358. doi: 10.4236/ojpm.2015.58039.

Conflicts of Interest

The authors declare no conflicts of interest.


[1] Fuster, V. and Kelly, B.B. (2010) Promoting Cardiovascular Health in the Developing World: A Critical Challenge to Achieve Global Health. National Academies Press, Washington (DC).
[2] Spruill, T.M. (2010) Chronic Psychosocial Stress and Hypertension. Current Hypertension Reports, 12, 10-16.
[3] Yusuf, S., Hawken, S., Ounpuu, S., et al. (2004) Effect of Potentially Modifiable Risk Factors Associated with Myocardial Infarction in 52 Countries (the INTERHEART Study): Case-Control Study. Lancet, 364, 937-952.
[4] Rosengren, A., Hawken, S., Ounpuu, S., et al. (2004) Association of Psychosocial Risk Factors with Risk of Acute Myocardial Infarction in 11,119 Cases and 13,648 Controls from 52 Countries (the Interheart Study): Case-Control Study. Lancet, 364, 953-962.
[5] Wachira, J.K. and Stys, T.P. (2013) Cardiovascular Disease and Bridging the Diagnostic Gap. South Dakota Medicine. The Journal of the South Dakota State Medical Association, 66, 366-369.
[6] Guessous, I., Bochud, M., Theler, J.M., et al. (2012) 1999-2009 Trends in Prevalence, Unawareness, Treatment and Control of Hypertension in Geneva, Switzerland. PloS One, 7, e39877.
[7] Heidenreich, P.A., Trogdon, J.G., Khavjou, O.A., et al. (2011) Forecasting the Future of Cardiovascular Disease in the United States: A Policy Statement from the American Heart Association. Circulation, 123, 933-944.
[8] Santschi, V., Chiolero, A., Burnand, B., et al. (2011) Impact of Pharmacist Care in the Management of Cardiovascular Disease Risk Factors: A Systematic Review and Meta-Analysis of Randomized Trials. Archives of Internal Medicine, 171, 1441-1453.
[9] Garcao, J.A. and Cabrita, J. (2002) Evaluation of a Pharmaceutical Care Program for Hypertensive Patients in Rural Portugal. Journal of the American Pharmaceutical Association, 42, 858-864.
[10] Kraemer, D.F., Kradjan, W.A., Bianco, T.M., et al. (2012) A Randomized Study to Assess the Impact of Pharmacist Counseling of Employer-Based Health Plan Beneficiaries with Diabetes: The EMPOWER Study. Journal of Pharmacy Practice, 25, 169-179.
[11] Planas, L.G., Crosby, K.M., Mitchell, K.D. and Farmer, K.C. (2009) Evaluation of a Hypertension Medication Therapy Management Program in Patients with Diabetes. Journal of the American Pharmacists Association: JAPhA, 49, 164-170.
[12] Fornos, J.A., Andres, N.F., Andres, J.C., Guerra, M.M. and Egea, B. (2006) A Pharmacotherapy Follow-Up Program in Patients with Type-2 Diabetes in Community Pharmacies in Spain. Pharmacy World & Science: PWS, 28, 65-72.
[13] Zillich, A.J., Sutherland, J.M., Kumbera, P.A. and Carter, B.L. (2005) Hypertension Outcomes through Blood Pressure Monitoring and Evaluation by Pharmacists (HOME Study). Journal of General Internal Medicine, 20, 1091-1096.
[14] Paulos, C.P., Nygren, C.E., Celedon, C. and Cárcamo, C.A. (2005) Impact of a Pharmaceutical Care Program in a Community Pharmacy on Patients with Dyslipidemia. The Annals of Pharmacotherapy, 39, 939-943.
[15] Sookaneknun, P., Richards, R.M., Sanguansermsri, J. and Teerasut, C. (2004) Pharmacist Involvement in Primary Care Improves Hypertensive Patient Clinical Outcomes. The Annals of Pharmacotherapy, 38, 2023-2028.
[16] Nola, K.M., Gourley, D.R., Portner, T.S., Gourley, G.K., Solomon, D.K., Elam, M., et al. (2000) Clinical and Humanistic Outcomes of a Lipid Management Program in the Community Pharmacy Setting. Journal of the American Pharmaceutical Association, 40, 166-173.
[17] McKenney, J.M., Slining, J.M., Henderson, H.R., Devins, D. and Barr, M. (1973) The Effect of Clinical Pharmacy Services on Patients with Essential Hypertension. Circulation, 48, 1104-1111.
[18] Swiss Law (2006) Swiss Law 02.01 RK Regulations K 3 02.01 on the Health Professions of the 22.6.2006—Chaptes III, Article 24. Le pharmacien doit user de son autorité pour inciter le patient à prendre toute mesure propre à la sauvegarde de sa santé [The Pharmacist Should Use Its Authority to Encourage the Patient to Take the Necessary Measures to Stay Healthy].
[19] Vandelanotte, C., Spathonis, K.M., Eakin, E.G. and Owen, N. (2007) Website-Delivered Physical Activity Interventions a Review of the Literature. American Journal of Preventive Medicine, 33, 54-64.
[20] Griffiths, F., Lindenmeyer, A., Powell, J., Lowe, P. and Thorogood, M. (2006) Why Are Health Care Interventions Delivered Over the Internet? A Systematic Review of the Published Literature. Journal of Medical Internet Research, 8, e10.
[21] Liu, S., Dunford, S.D., Leung, Y.W., Brooks, D., Thomas, S.G., Eysenbach, G., et al. (2013) Reducing Blood Pressure with Internet-Based Interventions: A Meta-Analysis. The Canadian Journal of Cardiology, 29, 613-621.
[22] Colkesen, E.B., Ferket, B.S., Tijssen, J.G., Kraaijenhagen, R.A., van Kalken, C.K. and Peters, R.J.G. (2011) Effects on Cardiovascular Disease Risk of a Web-Based Health Risk Assessment with Tailored Health Advice: A Follow-Up Study. Vascular Health and Risk Management, 7, 67-74.
[23] Hamblin, S., Rumbaugh, K. and Miller, R. (2012) Prevention of Adverse Drug Events and Cost Savings Associated with PharmD Interventions in an Academic Level I Trauma Center: An Evidence-Based Approach. The Journal of Trauma and Acute Care Surgery, 73, 1484-1490.
[24] Green, B.B., Cook, A.J., Ralston, J.D., Fishman, P.A., Catz, S.L., Carlson, J., et al. (2008) Effectiveness of Home Blood Pressure Monitoring, Web Communication, and Pharmacist Care on Hypertension Control: A Randomized Controlled Trial. JAMA, 299, 2857-2867.
[25] Guessous, I., Joost, S., Jeannot, E., Theler, J.-M., Mahler, P., Gaspoz, J.-M., et al. (2014) A Comparison of the Spatial Dependence of Body Mass Index among Adults and Children in a Swiss General Population. Nutrition & Diabetes, 4, e111.
[26] Guessous, I., Luthi, J.C., Bowling, C.B., Theler, J.-M., Paccaud, F., Gaspoz, J.-M., et al. (2014) Prevalence of Frailty Indicators and Association with Socioeconomic Status in Middle-Aged and Older Adults in a Swiss Region with Universal Health Insurance Coverage: A Population-Based Cross-Sectional Study. Journal of Aging Research, 2014, Article ID: 198603.
[27] Schubart, J.R., Stuckey, H.L., Ganeshamoorthy, A. and Sciamanna, C.N. (2011) Chronic Health Conditions and Internet Behavioral Interventions: A Review of Factors to Enhance User Engagement. Computers, Informatics, Nursing: CIN, 29, 81-92.
[28] McConnon, A., Kirk, S.F., Cockroft, J.E., Harvey, E.L., Greenwood, D.C., Thomas, J.D., et al. (2007) The Internet for Weight Control in an Obese Sample: Results of a Randomised Controlled Trial. BMC Health Services Research, 7, 206.
[29] Union IT.
[30] Schwartz, G.L., Turner, S.T., Moore, J.H. and Sing, C.F. (2000) Effect of Time of Day on Intraindividual Variability in Ambulatory Blood Pressure. American Journal of Hypertension, 13, 1203-1209.
[31] Vegting, I.L., Schrijver, E.J., Otten, R.H. and Nanayakkara, P.W.B. (2014) Internet Programs Targeting Multiple Lifestyle Interventions in Primary and Secondary Care Are Not Superior to Usual Care Alone in Improving Cardiovascular Risk Profile: A Systematic Review. European Journal of Internal Medicine, 25, 73-81.
[32] Erstad, B.L., Haas, C.E., O’Keeffe, T., Hokula, C.A., Parrinello, K. and Theodorou, A.A. (2011) Interdisciplinary Patient Care in the Intensive Care Unit: Focus on the Pharmacist. Pharmacotherapy, 31, 128-137.
[33] Walsh, J.M., McDonald, K.M., Shojania, K.G., Sundaram, V., Nayak, S., Lewis, R., et al. (2006) Quality Improvement Strategies for Hypertension Management: A Systematic Review. Medical Care, 44, 646-657.
[34] Walsh, J.M., Sundaram, V., McDonald, K., Owens, D.K. and Goldstein, M.K. (2008) Implementing Effective Hypertension Quality Improvement Strategies: Barriers and Potential Solutions. Journal of Clinical Hypertension, 10, 311-316.
[35] Swiss State Secretariat for Economics Affairs.
[36] College AAM. How to Fix the Doctor Shortage.
[37] Houle, S.K., Chuck, A.W., McAlister, F.A. and Tsuyuki, R.T. (2012) Effect of a Pharmacist-Managed Hypertension Program on Health System Costs: An Evaluation of the Study of Cardiovascular Risk Intervention by Pharmacists-Hypertension (SCRIP-HTN). Pharmacotherapy, 32, 527-537.
[38] Cote, I., Gregoire, J.P., Moisan, J., Chabot, I. and Lacroix, G. (2003) A Pharmacy-Based Health Promotion Programme in Hypertension: Cost-Benefit Analysis. PharmacoEconomics, 21, 415-428.
[39] Munroe, W.P., Kunz, K., Dalmady-Israel, C., Potter, L. and Schonfeld, W.H. (1997) Economic Evaluation of Pharmacist Involvement in Disease Management in a Community Pharmacy Setting. Clinical Therapeutics, 19, 113-123.
[40] Strong, D.K. and Tsang, G.W. (1993) Focus and Impact of Pharmacists’ Interventions. The Canadian Journal of Hospital Pharmacy, 46, 101-108.
[41] Alston, G.L. and Waitzman, J.A. (2013) The I-Tribe Community Pharmacy Practice Model: Professional Pharmacy Unshackled. Journal of the American Pharmacists Association: JAPhA, 53, 163-171.
[42] Noar, S.M. (2012) eHealth Applications: Promising Strategies for Behavior Change. Routledge, New York.

Copyright © 2022 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.